Alpine Associates Management’s scPharmaceuticals SCPH Stock Holding History

Alpine Associates Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-961,065	Closed	-$5.45M	–	90
2025 Q3	$5.45M	Buy	+961,065	New	+$4.92M	0.33%	52

Alpine Associates Management's SCPH Position: Q4 2025 in Review

Alpine Associates Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 961,065 shares — an estimated $5.45M sold.

Alpine Associates Management first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $5.45M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Alpine Associates Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Alpine Associates Management sold 961,065 scPharmaceuticals shares in Q4 2025, an estimated $5.45M.
Alpine Associates Management first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Alpine Associates Management's scPharmaceuticals position peaked at $5.45M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Alpine Associates Management's 13F filing for Q4 2025, filed 5 Feb 2026.